EX-10.17 28 d269096dex1017.htm CO-DEVELOPMENT AND DISTRIBUTION AGREEMENT Co- Development and Distribution Agreement between SurgiVision, Inc. and Brainlab Aktiengesellschaft CONFIDENTIAL Co-Development and Distribution Agreement between SurgiVision,...Co-Development and Distribution Agreement • May 5th, 2020 • Illinois
This Co-Development and Distribution Agreement (the “Agreement”) is entered into between SurgiVision, Inc., having its principal office located at 5 Musick, Irvine, California 92618, United States (“SurgiVision”), and Brainlab AG, a German corporation having its principal office located at Kapellenstrasse 12, 85622 Feldkirchen, Germany (“Brainlab”), as of April 5, 2011 (“Effective Date”).
CO-DEVELOPMENT AND DISTRIBUTION AGREEMENTCo-Development and Distribution Agreement • December 23rd, 2020 • Seneca Biopharma, Inc. • Biological products, (no disgnostic substances)
This Co-Development and Distribution Agreement (this “Agreement”) is made and entered into as of the 27th day of February, 2018 (the “Effective Date”) by and between Leading BioSciences, Inc., a corporation organized under the laws of Delaware having its office at 5800 Armada Drive, Ste. 210, Carlsbad, CA 92008 (“LBS”), and Biolead Medical Technology Limited, a limited company organized under the laws of the Hong Kong. LBS and Newsoara (defined below) are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
Biostimulants: InVivo Agriculture and Valagro sign a co-development and distribution agreementCo-Development and Distribution Agreement • September 15th, 2016
For InVivo Agriculture, this agreement is aligned with its 2025 strategy, which has defined the offer of topnotch biocontrol and biostimulants products to their cooperatives and farmers as a top priority. InVivo was advised by Laurent Vermer from Future Food Partners in the structuring and negotiation of the agreement
SECOND AMENDMENT TO CO-DEVELOPMENT AND DISTRIBUTION AGREEMENTCo-Development and Distribution Agreement • March 7th, 2013 • Mri Interventions, Inc. • Surgical & medical instruments & apparatus
This SECOND AMENDMENT (this “Second Amendment”) is made effective as of March 6, 2013 and is made in reference to that certain Co-Development and Distribution Agreement with an effective date of April 5, 2011 between MRI Interventions, Inc. (f/k/a SurgiVision, Inc.), a Delaware corporation (“MRI Interventions”) and Brainlab AG, a German corporation (“Brainlab”), as previously amended by that certain First Amendment dated as of July 18, 2011 (as amended, the “Agreement”).
